{"disease":{"id":"lower-risk-mds-per-ipss-r","name":"lower risk mds per ipss r"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05925504","title":"The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}